One important observation from this study is that, in the context of obesity, soluble chemerin levels enhanced both the inflammation and dysmetabolic phenotype, showing how an opposite change in the expression of CMKLR1 takes place once IR is established. The gene discussed is CMKLR1; the disease is obesity disorder.